Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Laura Stoppel currently holds 13,750 shares of Acumen Pharmaceuticals, Inc. (ABOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Laura Stoppel has been a net neutral trader of ABOS stock. They have purchased $0 and sold $0 worth of shares.
Laura Stoppel's most recent insider trade was on Sep 8, 2026, when they sold 13,750 shares at $0.00 per share.
Laura Stoppel serves as Executive at Acumen Pharmaceuticals, Inc. (ABOS). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Laura Stoppel holds the position of Executive at Acumen Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Laura Stoppel has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Laura Stoppel was on Sep 8, 2026, when they purchased $0 worth of ARTV shares. This transaction involved 13,750 shares at N/A per share.
Laura Stoppel currently owns 13,750 shares of Acumen Pharmaceuticals, Inc. (ABOS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Laura Stoppel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Laura Stoppel has 4 Form 4 filings on record as an insider at Acumen Pharmaceuticals, Inc..
Set alerts for Laura Stoppel and 40,000+ other insiders.